L-5-Methyltetrahydrofolate calcium, 97%

Name: L-5-Methyltetrahydrofolate calcium, 97% | 151533-22-1
Brand: J&K Chemical
SKU: JK1084285_25_MG
Price: 50.0 USD
Availability: InStock

Cat. No JK1084285_25_MG

Vendor: J&K Chemical

Product Information

Product Name

L-5-Methyltetrahydrofolate calcium, 97%

Brand Name

J&K

Product Number

1084285

CAS

151533-22-1

Molecular Formula

C20H25CaN7O6

Molecular Weight

499.53

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

Levomefolate calcium

PubChem CID

135564391

Properties

Melting Point

>300

Safety Information

Precautionary Statement

P262

Storage Condition

Freezer -20℃

References Data Source From Pubchem

[Clinical Preparations: Status Quo and Challenges in the Future]

Publication Name: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Publication Date: 2019

DOI: 10.1248/yakushi.19-00121-1

A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)

Publication Name: Cancer Chemotherapy and Pharmacology

Publication Date: 2018-07-20

DOI: 10.1007/s00280-018-3648-y

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans

Publication Name: Drug Discovery Today

Publication Date: 2016-04

DOI: 10.1016/j.drudis.2016.02.015

Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs

Publication Name: The Journal of Clinical Psychiatry

Publication Date: 2015-11-10

DOI: 10.4088/jcp.14m09587

Comprehensive evaluation of Safyral(®) 2012

Publication Name: Women's health (London, England)

Publication Date: 2012-11

DOI: 10.2217/whe.12.50

L-5-Methyltetrahydrofolate calcium, 97%

Product Information

General Information

Properties

Safety Information

References Data Source From Pubchem

[Clinical Preparations: Status Quo and Challenges in the Future]

A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans

Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs

Comprehensive evaluation of Safyral(®) 2012